Related Experiment Video

Updated: Jun 21, 2026

Reverse Yeast Two-hybrid System to Identify Mammalian Nuclear Receptor Residues that Interact with Ligands and/or Antagonists
10:51

Reverse Yeast Two-hybrid System to Identify Mammalian Nuclear Receptor Residues that Interact with Ligands and/or Antagonists

Published on: November 16, 2013

Beta-arrestin 2 modulates the activity of nuclear receptor RAR beta2 through activation of ERK2 kinase

F Piu1, N K Gauthier, F Wang

  • 1ACADIA Pharmaceuticals Inc., San Diego, CA 92121, USA. fpiu@acadia-pharm.com

Oncogene
|September 20, 2005
PubMed

Insights

Beta-arrestin 2 enhances retinoid receptor activity, particularly RAR beta2, through ERK2 signaling. This pathway is crucial for Nerve Growth Factor-induced PC12 cell growth inhibition.

Area of Science:

  • Molecular Biology
  • Cell Signaling

Background:

  • Retinoid receptor activity is modulated by extracellular signals.
  • Beta-arrestins are involved in receptor internalization and MAPK activation.

Purpose of the Study:

  • To investigate the role of beta-arrestins in regulating retinoid receptor activity.
  • To elucidate the molecular mechanisms underlying beta-arrestin-mediated signaling.

Main Methods:

  • Investigated beta-arrestin 2's effect on RAR and RXR transcriptional activity.
  • Utilized site-directed mutagenesis to identify critical residues.
  • Assessed the role of specific MAP kinases (ERK2, JNK, P38).
  • Examined the dependence of NGF-induced PC12 growth inhibition on this pathway.

Main Results:

  • Beta-arrestin 2 significantly stimulates the transcriptional activation of RAR and RXR receptors.
  • RAR beta2 subtype exhibits the highest sensitivity to beta-arrestin 2.
  • This stimulation is dependent on ERK2, but not JNK or P38.
  • Ser 22 and Leu 217 were identified as critical residues in RAR beta2 for beta-arrestin 2 interaction.
  • Nerve Growth Factor-induced PC12 growth inhibition relies on RAR beta2 activation mediated by beta-arrestin 2 and ERK2.

Conclusions:

  • Beta-arrestin 2 acts as a positive regulator of RAR and RXR transcriptional activity.
  • The RAR beta2 receptor is a key mediator in beta-arrestin 2 and ERK2 signaling pathways.
  • This pathway plays a significant role in cellular responses to growth factors like NGF.

More Related Videos

Studying RNA Interactors of Protein Kinase RNA-Activated during the Mammalian Cell Cycle10:05

Studying RNA Interactors of Protein Kinase RNA-Activated during the Mammalian Cell Cycle

Published on: March 5, 2019

Monitoring GPCR-β-arrestin1/2 Interactions in Real Time Living Systems to Accelerate Drug Discovery08:21

Monitoring GPCR-β-arrestin1/2 Interactions in Real Time Living Systems to Accelerate Drug Discovery

Published on: June 28, 2019

Related Concept Videos

Co-activators and Co-repressors02:04

Co-activators and Co-repressors

Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
Regulation of Nuclear Protein Sorting01:45

Regulation of Nuclear Protein Sorting

Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
The Two-State Receptor Model01:29

The Two-State Receptor Model

The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with one...